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Abstract 
A series of p-cymene and cyclopentadienyl Ru(II)-aNHC complexes have been synthesized from 2-
methylimidazolium salts with either an N-bound alkenyl (1, 3) or picolyl tether (6, 7). The C(5)-Me 
substituted alkenyl-tethered analogues (2, 4) have also been synthesized. Ag-mediated C(2)-
dealkylation was a prominent side reaction that led to the formation of normally bound NHC Ru(II) 
complexes, which in selected cases have been isolated (5, 8). A C(4)- over C(2)-selectivity for 
ruthenium binding has been established by protecting the C(2)-position with an iPr group on the 
imidazolium precursor, for which unique p-cymene (9) and cyclopentadienyl (10) Ru(II)-aNHC 
derivatives have been synthesized. All complexes were applied in the transfer hydrogenation of 
ketones and in secondary alcohol oxidation, with higher catalytic activity for the p-cymene over the 
cyclopentadienyl systems, as well as the alkenyl- over the picolyl-containing aNHC complexes. 
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Introduction 
N-heterocyclic carbenes (NHCs) have the ability to exhibit both innocent and non-innocent behavior 
in metal-mediated transformation reactions.1–3 Therefore it is not surprising that these stabilizing 
ligands have been coordinated to most of the transition metals in a range of different oxidation states. 
NHCs are known to form some of the strongest M–C bonds,4,5 and hence attempts have been directed 
towards the synthesis of highly electron-donating NHCs in order to better stabilize sensitive transition 
metal species, as well as to access high oxidation state metal species.2,3 It has also been shown that 
C(4)/C(5)-bound imidazolylidenes (a subclass of so-called abnormal NHCs, aNHCs) are significantly 
stronger donors compared to their classical C(2)-bound imidazolylidene counterparts (Figure 1).3 The 
enhanced donor properties imparted by aNHCs has been shown to further improve the catalytic 
efficiency of these metal complexes in a variety of reactions.2,4 A range of different backbone- and 
N-functionalized aNHCs have been reported with tunable donor properties that are significantly 
influenced by both the number and positions of heteroatoms within the heterocycle (Figure 1), with 
subsequent catalytic implications.5 For example, the pronounced mesoionic character of the aNHC 
ligand allows for the usual carbene-type stabilization when coordinated to low-valent electron-rich 
metals, whereas a carbanionic character may be dominant with electron-poor, high-oxidation state 
metal centers.2,6  
 
Figure 1: Order of donor strength of imidazolylidene and pyrazolylidene-based NHCs. 
 
Despite these attractive advantages of aNHCs, the organometallic chemistry of NHCs remains 
dominated by normally bound NHC complexes.4 A major limitation of aNHC complexes is the 
synthetic accessibility because of the low acidity of the imidazolium C(4)/C(5) proton,7 which 
requires specific protocols to direct metalation at this position.7,8  
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Protection of the imidazolium C(2) position with alkyl or aryl substituents is probably the most 
rational and useful route that has been developed for selective metal coordination to the 
imidazolylidene C(4) atom.4,5(a) However, the formation of C(4)-bound aNHCs via transmetallation 
of the corresponding Ag-aNHC intermediate is generally limited because of redox reactions of the 
imidazolium salt with the strong oxidant Ag2O.3 The need for more facile routes to access these 
desirable aNHCs remains relevant, as the rational preparation of aNHC metal complexes continues 
to be a synthetic challenge.4,9,10 One attractive strategy, particularly for aNHCs, is chelate-assisted C–
H bond activation.11 In this approach a variety of donor groups such as alkenyl, picolyl, pyridyl, 
thioether, amine, oxo, or phosphine substituents are grafted onto the C(2)-protected NHC scaffold, 
usually through N-alkylation, essentially forming a bidentate aNHC ligand precursor. Abnormal 
coordination selectivity has also been related to steric control imparted by the tether length and the 
bite angle, as well as to the nature of the anion of the aNHC precursor.12 In addition, such N-
substituted chelators may exhibit hemilability and non-innocent behavior in solution, which enhances 
the set of metal-specific steps within a potential catalytic cycle.13 In light of the latter, the lack of 
exploitation of potentially hemilabile bidentate aNHC ligand systems prompted us to evaluate the 
catalytic potential of chelating aNHC ligands when bound to a ruthenium metal center. Even though 
only a small number of well-defined aNHC Ru complexes have been reported to date, most of these 
complexes exhibit superior catalytic activities compared to their normally bound analogues.3(a),14 Here 
we report the synthesis of eight new abnormally bound NHC half-sandwich Ru(II) complexes and 
demonstrate the strong binding of these aNHC ligands through acid stability studies. In addition, the 
novel complexes have been evaluated for their application in transfer (de)hydrogenation catalysis. 
Each of these Ru(II) complexes is comprised of either an alkene- or picolyl-substituent as one of two 
possible N-functionalized chelating moieties. In addition, selectivity and yield issues typically 
encountered with Ag2O-assisted carbene transfer reactions are addressed. 
 
 
Results and Discussion 
Synthesis of the NHC ligands. The four aNHC ligand precursors [HL1]Cl–[HL4]Cl were 
synthesized from the respective C(2)-substituted imidazoles (Scheme 1). For example, 1,2-
dimethylimidazole reacts with either 3-chloro-2-methyl-propene or 2-(chloromethyl)pyridine in a 
quaternization reaction to produce the C(2)-protected imidazolium chloride salts in excellent yields 
(93%, [HL1]Cl; 88%, [HL2]Cl). The tetra-substituted imidazolium salt [HL3]Cl was accessed by 
reacting 2,4-dimethylimidazole first with acetic anhydride, followed by methyl iodide to selectively 
yield the 1,2,5-trimethyl imidazole. It was found previously that direct deprotonation and alkylation 
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of 2,4-dimethylimidazole gave mixtures of the 1,2,4-, and 1,2,5-trisubstituted imidazoles.15 The 1,2,5-
trimethylimidazole precursor was further reacted with 3-chloro-2-methyl-propene to obtain [HL3]Cl 
in moderate yield (53%). In an attempt to address selectivity issues in the metalation (see below), the 
symmetrical aNHC precursor [HL4]Cl was synthesized in high yield by sequential treatment of 2-
isopropylimidazole with KOH and 3-chloro-2-methylpropene, followed by another equivalent of 3-
chloro-2-methyl-propene (90%).  
 
 
Scheme 1: Synthesis of the aNHC ligand precursors. 
 
The 1H NMR spectra of [HL1]Cl, [HL3]Cl, and [HL4]Cl all showed characteristic singlets for the 2-
methylpropenyl moiety at δH 1.53–1.78 (CH3), 4.60–4.82 (NCH2), and 4.51–5.06 (two singlets, 
=CH2). Depending on the symmetrical nature of the ligand, the imidazolium backbone protons either 
appeared as a singlet at δH 7.47 ([HL4]Cl) or 7.14 ([HL3]Cl), or as two singlets (δH 7.51 and 7.78 for 
[HL1]Cl, 7.46 and 7.64 for [HL2]Cl).16 Although only 13C, 15N, 31P, and 77Se NMR techniques are 
classically used to compare σ-donor and π-accepting properties of various NHC ligands,17 it is 
interesting to compare the values of the aromatic imidazolium 1H NMR signals of L1–L4 to gauge 
σ-donor strength: L1 < L2 < L4 < L3. According to this series, ligand L3 bearing a C(5)-Me group 
is more donating than its C(5)-H counterpart, L1, as might be expected from the inductive effect of a 
NN
CH3CN, reflux
NN
NN
ClCl
NHN NN
Cl
NN
(ii) MeI, reflux
(i) Ac2O, benzene
reflux
CH3CN, reflux
NN
Cl
CH3CN, refluxCH2Cl2, KOH
reflux
NHN
[HL1]Cl
Cl
N
CH3CN, reflux
NN
Cl
N
Cl
ClCl
1
2
3
45
1
2
3
4
5
1
2
3
45
[HL2]Cl
[HL3]Cl
[HL4]Cl
 
 
5 
 
methyl substituent. This approximate donor strength series is supported when comparing the 
increasing resonance frequency of the pre-carbenic C(4)-signal in the 13C NMR spectra in the series 
122.4 ppm ([HL2]Cl) 122.9 ppm ([HL1]Cl), 123.7 ppm ([HL4]Cl), 129.7 ppm ([HL3]Cl). 
 
Synthesis of the normal and abnormal NHC Ru(II) complexes. Each of the ligands L1-L4 
contains a C(2)-alkyl substituent to inhibit metal coordination at the normal position of the NHC. 
Metallation was carried out using standard literature procedures3,18 which involves reacting the 
imidazolium salt with Ag2O under exclusion of light to form the carbene silver complex in situ, and 
subsequently treating the reaction mixture with the appropriate ruthenium(II) precursor (Scheme 2). 
This procedure afforded the aNHC ruthenium(II) complexes 1 and 2 from the reaction of [HL1]Cl 
and [HL3]Cl, respectively, with [(p-cymene)RuCl2]2 in moderate yield (49% and 38%, 
respectively).19 Transmetallation with [CpRuCl(PPh3)2] gave the aNHC complexes 3 and 4, 
respectively. While complex 3 was the only detectable product when starting from the trisubstituted 
imidazolium salt [HL1]Cl, the tetrasubstituted imidazolium salt [HL3]Cl afforded, in addition to the 
aNHC complex 4, also the normal NHC complex 5. Similar C(2)-Calkyl bond cleavage was observed 
previously,3(b) in particular with methyl, ethyl, and benzyl substituents at C(2).4(b) Conversely, no 
dealkylation occurs when the C(2) substituent is a bulky, secondary alkyl or an aryl group such as 
iso-propyl or phenyl.1(d),3(b) The yields of complexes 1–5 were only moderate (19-49%), and 
complexes 1 and 2 formed slightly better (>38% yields) owing to the higher reactivity of [(p-
cymene)RuCl2]2 vs. [CpRuCl(PPh3)2].  
 
Scheme 2: Synthesis of aNHC half-sandwich Ru(II) complexes with an alkenyl chelating group. 
 
 
 
6 
 
Spectroscopic evidence of aNHC coordination in complexes 1–4 was obtained from the 
disappearance of the low-field 1H NMR signal due to the C(4)-H proton and the downfield shift of 
the corresponding 13C NMR resonance from around 125 ppm to 147.0–171.1 ppm. Moreover, the 1H 
NMR signals for the spectator p-cymene or cyclopentadienyl ligand appeared in an equimolar ratio 
to the carbene ligand. In addition, a slight upfield shift of the C(5)–H proton was observed from δH 
7.51 in [HL1]Cl to 7.41 (1) and 7.02 (3), respectively, indicative of higher electron density on the 
C(4) position. Alkene coordination was also confirmed by 1H NMR spectroscopy, as the signals of 
the symmetric NCH2 methylene protons from the ligand salts (singlet around δH 4.7) split into AB 
doublets upon coordination (2JHH = 9–15 Hz) due to their diastereotopic nature. The generally large 
chemical shift differences between the coupling doublets ( up to 1.6 ppm) indicates distinctly 
different chemical environments for the two NCH2 protons, which suggests rigid alkene coordination. 
 
Despite successive attempts, complete separation of 4 and 5 by either column chromatography or 
solvent extraction has failed so far. The 1H and 31P NMR spectrum of the mixture of abnormal/normal 
NHC complexes indicates an approximate 2:1 ratio of 4 and 5. Characteristically, the aNHC complex 
4 features an NMR signal at δH 2.92 for the C(2)-CH3 protons, whereas complex 5 shows a diagnostic 
resonance at δH 6.74 for the C(4)-bound proton. The presence of a methyl substituent on C5 in ligand 
L3 leads to a substantial preference for C(2)-dealkylation and provides the normally bound NHC as 
the major product. This result is attributed to a lower acidity of the C(4)–H proton in [HL3]Cl (cf. 
NMR data), which reduces the deprotonation propensity of Ag2O in favor of C(2)-Me oxidation. 
 
Upon changing the type of chelate from an olefin to pyridine, i.e. employing [HL2]Cl with an N-
picolyl substituent, provided a similar outcome and afforded complexes 6–8 in moderate yields 
(Scheme 3). Even though imine interactions with Ag+ are more prominent,12 yields of aNHC-Ru(II) 
complexes did not appreciably increase compared to complexes 1–4 with an olefin wingtip 
functionality. Again, abnormal NHC coordination was indicated by the disappearance of the 1H NMR 
signal of C(4)–H (δH 7.64 in [HL2]Cl), along with a slight upfield shift of C(5)–H (δH 6.58 and 6.64 
for 6 and 7, respectively), as well as the deshielding of the corresponding C(4)–Ru carbene signal to 
δC 157.8 and 159.9, respectively. Chelation of the picolyl moiety was supported by the characteristic 
downfield shift of the ortho proton of the pyridyl substituent (δH 9.36 for 6; 8.25 for 7) and by the 
splitting of the methylene linker into an AB signal (2JHH = 15–18 Hz). Separation attempts of 
complexes 7 and 8 failed, even after numerous attempts at recrystallization and column 
chromatography. Distinct NMR signals of the C(4/5)–H at δH 6.34 and 6.44 as well as a low-field 
resonance at δC 184.4 for the C(2)–Ru nucleus indicate the presence of the normally bound NHC 
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ruthenium complex 8 in about equal quantities (ratio 7/8 is 0.46:0.54 according to 1H and 31P NMR 
integration). 
 
Scheme 3: Synthesis of picolyl-functionalized aNHC half-sandwich Ru(II) complexes. 
 
Crystallographic characterization of the complexes. The molecular structures and carbene 
bonding modes deduced from NMR studies were unequivocally supported by X-ray diffraction 
studies for complexes 1, 3, and 5–8 (Figure 2, Figure 3).20,21,22 All of the half-sandwich Ru(II) 
complexes assumed the typical three-legged piano stool structures.18 Selected bond lengths and angles 
are summarized in Table 1 and Table S4 (SI). If chelation of the alkene-tether in complexes 1–4 is 
considered to form pseudo-five membered ruthenacyles, the resulting bite angles vary between 
89.49(1) and 90.45(2)°, marginally wider than with the normally bound NHC in 5 at 89.10(1)°. The 
picolyl-containing complexes 6–8 feature a six-membered metallacycle and exhibit slightly more 
acute chelate bite angles of 85.7(3)–86.6(2)°. They exhibit synclinal torsion angles between the 
pyridyl and imidazolylidene mean planes between –48.60(3) and –55.08(6)°, while the alkene-
containing complexes (1, 3, 5) exhibit anticlinal torsion angles in the –108.369(4)° to –122.675(2)° 
range. This inclination renders the NHC and the alkene units closer to a co-planar arrangement. 
Interestingly, the Ru–C(4) bond distance of the aNHC complexes (average Ru–C 2.05(1) Å for 
complexes 1, 3, 6, 7) is shorter than the Ru–C(2) bond distance in the normal NHC complex 8 (Ru–
C 2.099(4) Å). This might either point to a stronger Ru–C(4) bond (abnormal vs. normal NHC), or 
may be due to the presence of a potentially shielding pseudo-ortho methyl group in 8. All Ru–Ccarbene 
bond distances are in good correlation with the bond distances of other related normal18 and 
abnormal21,23 NHC Ru(II) complexes.  
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Figure 2: ORTEP plots of compounds 1 and 3. Thermal ellipsoids are drawn at 50% level. For clarity, 
the phenyl moieties of PPh3 are shown as wireframe presentations, and non-coordinating anions and 
hydrogens are omitted. 
 
 
 
Figure 3: ORTEP plots of complexes 5–8. Thermal ellipsoids are drawn at 50% level. For clarity, 
the phenyl moieties of PPh3 are shown as wireframe presentations, and non-coordinating anions and 
hydrogens are omitted (structures of 7 and 8 have been obtained from a co-crystal). 
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Table 1: Selected bond lengths (Å) and angles (º) of complexes 1, 3, 5–8, and 10 
 1 3 5 6 7 8 10 
Ru1–C4 2.045(3) 2.0586(2) 2.032(4)c 2.045(2) 2.057(6) 2.099(4)c 2.046(2) 
Ru1–Cg a 1.728(3) 1.866(3) 1.905(3) 1.691(2) 1.853(6) 1.856(6) 1.899(4) 
Ru–Cl1 2.4114(7) - - 2.4075(6) - - - 
C4–Ru1–E 89.49(1)b 90.45(2)b 89.10(1)b,c 85.94(8)d 86.6(2)d 85.7(3)c,d 91.31(8)b 
a Cg = centroid of arene/cyclopentadienyl moiety; b E = Average position between two alkenyl carbon atoms; c 
C2 replaces C4 for C(2)-bound (normal) NHC d E = Nitrogen atom of pyridyl moiety. 
 
 
The difficulty in separating complexes 7 and 8 is demonstrated by the fact that crystallization led 
repetitively to co-crystallization and afforded crystals that contained both complexes 7 and 8. Two 
different unit cells were obtained from X-ray diffraction analysis, each with unique disorders, when 
either CH2Cl2 or CHCl3 was used as crystallization solvent (Figures S36, S37). These crystals 
constitute one of the rare examples where, regardless of the solvent used, disordered crystals contain 
two co-crystallized complexes as unique polymorphs. Co-crystallization may be facilitated by the 
similar steric environment that the methylimidazole and pyridyl moieties of the NHC ligand exhibit,24 
which renders these two entities of the chelating ligand almost identical in each of the complexes. 
 
Selectivity aspects of C4/C5–H activation. Different effects may contribute to the low yields 
obtained for the abnormal carbene complexes, including (i) occurrence of side reactions due to the 
relatively strong C4–H bond, (ii) the strongly oxidizing nature of Ag2O that may cause ligand 
degradation and/or C2-metallation, (iii) lack of selectivity between C4/C5-unsubstituted ligand 
precursors, and ensuing divergence of product stability as a result of chelation vs. monodentate 
bonding. We reasoned that the symmetric carbene precursor ([HL4]Cl), i.e. the ligand bearing 
stabilizing alkenyl units adjacent to both the C(4) and the C(5) position, alleviates the drawbacks 
from the low selectivity of Ag carbene formation. Furthermore, L4 features a C(2)-isopropyl 
substituent that is resistant to Ag-mediated dealkylation,3(b) which further minimizes formation of 
side products such as normal carbene complexes. Reaction of [HL4]Cl with Ag2O and [(p-
cymene)RuCl2]2 or [CpRuCl(PPh3)2] gave complexes 9 and 10, respectively (Scheme 4). Yields were 
indeed significantly higher (62% and 55%, for 9 and 10, respectively) and without formation of 
detectable side-products.  
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Scheme 4: Formation of the C(2)-isopropyl functionalized Ru(II)-aNHC complexes 9 and 10. 
 
Similar to the aNHC ruthenium complexes described above, complexes 9 and 10 showed distinct 
signals of abnormal carbene bonding in their NMR spectra, including the disappearance of the C(4)–
H signal at δH = 7.47, an upfield shift of the C(5)–H resonance to δH = 7.17 (9) and 6.75 (10), and a 
downfield shift of the C(4)–Ru signal to δC = 152.3 (9) and 148.6 (10). Chelation was deduced from 
the shift of the olefinic signals from δH = 4.58 and 5.06 ([HL4]Cl, Δδ = 0.48 ppm) to 4.03 and 5.51 
(9, Δδ = 1.48 ppm), and to 2.27 and 3.65 (10, Δδ = 1.38 ppm). The molecular structure of 10 further 
confirmed the bidentate nature of L4, with a pseudo-bite angle of 91.31(8)° and a Ru–C(4) bond 
distance of 2.046(2) Å (Figure 4), similar to the analogous complexes 1 and 3. 
 
Figure 4: ORTEP plot of compound 10. Thermal ellipsoids are drawn at 50% level. For clarity, the 
phenyl moieties of PPh3 are shown as wireframe presentations, and non-coordinating anions and 
hydrogens are omitted. 
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Acid stability. In order to probe the robustness of the Ru–C(4) bond in the novel aNHC complexes, 
the stability of these complexes in an acidic environment was investigated for complexes 1 and 3 as 
representatives of p-cymene and cyclopentadienyl systems, respectively. Figure 5 shows the 1H NMR 
spectra of 1 in acetone-d6 upon addition of various equivalents of DCl (1 M, D2O solution). While up 
to 12 equivalents of DCl did not indicate any cleavage of the Ru–C4 bond, three distinct events have 
been identified upon DCl titration of a solution of complex 1: 
(i) Rapid H/D isotope exchange at C5: Addition of one equivalent of DCl led to an immediate 
decrease of the signal at δH 7.41 only, and full disappearance after addition of 6 equiv. 
DCl, indicating deuteration of the C(5) position. This reactivity was observed in similar 
aNHC complexes of Ir and Rh, and is indicative of the non-innocent character of the aNHC 
ligand.15 For example, it has been suggested that the strongly mesoionic character of the 
imidazolylidene ligand may facilitate dearomatization. This is followed by the addition of 
a proton to a formal metalla-allyl anionic fragment.15(a) The deuteration at C(5) is 
attributed to the presence of DCl, since a control experiment using only D2O (> 12 
equivalents) resulted in no deuteration of the ligand at all. The protio vs. deuterio ratio at 
C(5) follows a rapid decrease after addition of DCl from 80% (1 eq.) to 29% (2 eq.), 13% 
(4 eq.), and <1% (8 eq.). No formation of the free aNHC ligand or the corresponding 
imidazolium salt was observed, even upon heating of the solution to 40 °C for several 
hours, which underpins the robustness of the Ru-carbene bond. 
(ii) p-cymene dissociation: Already in the presence of 1 equivalent of DCl, new signals 
appeared at δH 7.09 (q, 3JHH = 6 Hz), 2.84 (m), 2.25 (s), and 1.20 (d, 3JHH = 9 Hz), 
corresponding to free p-cymene (17%; full spectra in Fig. S3, S4). In agreement with 
cymene loss, the intensity of the doublets corresponding to the coordinated p-cymene 
ligand gradually decreased (cf. δH 6.65, 6.50, 5.80, 5.27). The relative amount of bound p-
cymene was 83% upon addition of 1 eq. DCl (2 h), and 70% in the presence of 8 eq. DCl 
(1 day). The signals for the coordinated p-cymene ligand do not fully disappear even after 
addition of 12 equivalents of DCl, which might be indicative of an equilibrium existing 
between free and bound p-cymene. Deuteration of the C(5)–H is not expected to affect p-
cymene dissociation, especially since the signals of coordinated p-cymene remain after 
full deuteration of C(5) . 
(iii) Alkene dissociation: Dissociation of the p-cymene ligand generates three available 
coordination sites on the ruthenium(II) center. With increasing quantities of aqueous DCl, 
the propensity for the formation of (aNHC)Ru–OD2 species increases.25 After addition of 
more than 8 equivalents of DCl, a series of ten new signals appear including three doublets 
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at δH 6.01, 5.46, and 5.31, all with identical coupling constant 3JHH = 6 Hz, in an 
approximate ratio of 1:4:4. Of the remaining seven singlets (δH 5.07, 4.90, 4.77, 3.98, 2.75, 
2.11, and 1.27), the four signals at δH 5.07, 4.90, 4.77, and 1.27 correspond to the free 
alkenyl tether, suggesting monodentate coordination of the aNHC ligand to the Ru(II) 
center. Such bonding indicates that all organic ligands in complex 1 are more labile in an 
acidic environment than the aNHC ligand. After addition of more than 12 equivalents of 
DCl and over a period of ten days, the 1H NMR spectrum reveals signals which suggest 
that a remarkably acid- and moisture-stable aNHC Ru(II) complex remains in solution, 
although it has lost the p-cymene ligand and the N-alkenyl tether is unbound. A robust 
Ru–CaNHC bond is further supported by the carbenic resonance at δC 171.1, which 
remained present over the whole duration of this experiment. Even though the formed 
compound appears to be stable, attempts to isolate it have not been successful so far. 
 
A similar H/D isotope exchange was observed with the analogous cyclopentadienyl-containing 
complex 3, where an immediate deuteration of the C(5)–H proton was indicated by the loss of the 
signal at δH 7.02. No sign of deuteration of the cyclopentadienyl or the alkenyl unit was noted. Instead, 
complex 3 was fairly stable in an acidic environment with the cyclopentadienyl, carbene, and N-
alkenyl tether remaining intact upon increasing the amounts of added DCl up to 12 equivalents. 
Addition of DCl also led to the appearance of new, unassigned signals at δH 5.27, 5.35, and 5.62. 
However, no support for the loss of cyclopentadiene was obtained even over prolonged periods of 
heating to 40 °C and only a gradual deuteration of all signals was observed after two weeks. 
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Figure 5: 1H-NMR spectra of complex 1 upon titration with DCl showing resonances of complex 1 
(a–d), free p-cymene (▲) and an aNHC Ru complex with non-coordinating N-alkenyl tether (●). 
 
Transfer hydrogenation. Similar to the series of normal- and abnormal-NHC Ru(II) complexes 
described in the literature,26 complexes 1–10 were active in the transfer hydrogenation of selected 
ketone compounds. Standard conditions were employed, i.e. excess isopropanol as a hydrogen donor, 
base (KOH/KOtBu) as activator, and benzophenone as model substrate. Both 1H NMR and GC 
analyses of reaction mixtures in the presence of suitable internal standards suggested a selective 
reaction, and hence substrate conversions correspond to product yields. After reaction optimization 
involving catalyst loading, base, and reaction time (see Table S5), complexes 1–10 were screened for 
their catalytic activity. Using complexes 1 (p-cymene) and 3 (cyclopentadienyl) as catalysts, initial 
turnover frequencies TOFini = 60 h–1 and 26 h–1, respectively, were determined (TOFini after 15 min 
reaction time; Table 2, entries 1,3). While these rates are around three orders of magnitude lower than 
some of the best-performing ruthenium-based catalysts,2(c),26 they are comparable to similar bidentate 
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NHC Ru(II) analogues.2(c),11(b) Nonetheless, complexes 1 and 3 performed considerably better than 
the precursor salts (entries 9,10), revealing a direct impact of the tethered aNHC ligand on the 
catalytic activity. 
 
Table 2: Transfer hydrogenation of benzophenone using complexes 1–10 a 
 
 
 
Entry Complex NHC  
N-tether 
Spectator ligand 
system 
Conversion c (%) TOFinid (h–1) 
2h 6h 
1 1 alkenyl p-cym/Cl 63  93  60 
2 2 alkenyl p-cym/Cl 52  76  38 
3 3 alkenyl Cp/PPh3 32  69  26 
4 4/5b alkenyl Cp/PPh3 37  50  24 
5 6 picolyl p-cym/Cl 52 73 34 
6 7/8b picolyl Cp/PPh3 30 50 22 
7 9 alkenyl p-cym/Cl 60 89 58 
8 10 alkenyl Cp/PPh3 42 61 46 
9 [(p-cym)RuCl2]2 -- p-cym/Cl n.d. 8e n.d. 
10 [Cp)RuCl(PPh3)2] -- Cp/PPh3 n.d. 6e n.d. 
 
a General conditions: Benzophenone (0.6 mmol), iPrOH (5 mL), base (5 mol%), [Ru] (1 mol%), reflux. Base used 
depending on Ru catalyst: KOH (1, 2, 6, 9); KOtBu (3-5, 7, 8, 10); b mixture of complexes as isolated after purification; 
c determined by GC, based on the average of at least two runs; d determined after the first 15 minutes reaction time; e after 
18 h. 
 
Although chelation generally renders a more robust and longer-lived catalyst, it might inhibit 
substrate binding and hence reduce the overall yield.2(c),26 Both complexes 1 and 3 demonstrate good 
longevity and provide high yields after 6 h (93% for complex 1) and continued activity of complex 
3, which reaches a mere 50% conversion after 6 h but remains active and accomplishes 81% 
conversion after 18 h. When comparing classes of complexes, the p-cymene Ru(II) systems 
consistently outperformed the cyclopentadienyl Ru(II) analogues with the same NHC ligand 
(compare entries 1 vs. 3; 2 vs. 4; 5 vs. 6; 7 vs. 8), presumably because alkoxide coordination is easier 
by substitution of the chloride ligand than by replacing any of the ligands in the Cp complexes. For 
the cyclopentadienyl Ru(II) complexes to be catalytically active, the most obvious activation 
pathways include either alkene or phosphine dissociation, which is disfavored due to chelation and 
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the strong Ru–P bond, respectively (cf. the stability of the alkenyl tether in the Cp complexes under 
acidic conditions). The efficiency of the transfer hydrogenation reaction is temperature- and base-
dependent. Under base-free conditions, only low conversions were obtained that did not exceed 30% 
(18 h). Similarly, less than 10% benzophenone was converted after 6 h when the reaction was 
conducted at room temperature. A blank reaction in the absence of a catalyst showed negligible 
background conversion with 4% product observed after 18 h (5 mol% KOtBu). A change of the base 
from KOH to KOtBu induced a marginal increase of conversion for the cymene-containing complexes 
(6% after 2 h). The effect is much more substantial with the cyclopentadienyl Ru complexes, which 
are only very poorly active in the presence of KOH and required KOtBu to induce catalytic turnover.  
 
Introduction of a methyl group at C(5) of the  aNHC ligand (complex 2) lowered the performance 
slightly when compared to the analogue containing a C(5)–H unit (complex 1, cf. entries 1,2), despite 
the fact that the aNHC ligand in 2 is slightly more donating. The lower performance may therefore 
be attributed to steric effects, which are particularly relevant for inner sphere mechanisms. Changing 
the chelate from an N-alkene tether to an N-picolyl substituent (complex 6) reduces the catalytic 
activity of the ruthenium center (entry 1 vs. 5), which highlights the importance of chelate group 
tailoring. The C(2)–iPr functionalized NHC Ru complex 9 performed essentially identical to complex 
1, indicating that the C(2)-substituent (Me vs. iPr) on the aNHC ligand does not affect the catalytic 
activity of the metal center (entry 7). The catalytic activity of the abnormal/normal NHC Ru mixtures 
(4/5 and 7/8) was consistently lower after 6h, compared to that of the purely aNHC Ru complexes 
with a Cp spectator ligand (3, 10; cf. entries 3, 4, 6, and 8), hinting to a beneficial effect of the 
abnormal NHC bonding mode. 
 
Variation of the substrate demonstrates that steric and electrochemical differences in the substrate 
notably affect conversion (Table 3), i.e. less bulky substrates (acetophenone vs. benzophenone) and 
electron-donating substituents such as methoxy-groups resulted in higher conversions (98%) after 18 
h. Conversions were lower with substrates containing electron-withdrawing groups such as 4'-chloro- 
and 4'-nitro-acetophenone (entries 2, 3). In addition, the conversions of 2'- and 4'-
hydroxyacetophenone substrates were relatively low, presumably because the acidic phenol 
functionality impedes substrate coordination and instead forms an inactive Ru phenolate species. 
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Table 3: Substrate screening in the transfer hydrogenation reaction using 1 as catalyst precursor a 
 
Entry Substrate 
Conversion b 
(%) 
2h 18h 
1 Benzophenone 63 96 
2 Acetophenone 56 98 
3 4'-Chloroacetophenone 34 87 
4 4'-Nitroacetophenone 18 53 
5 4'-Hydroxyacetophenone 24 71 
6 2'-Hydroxyacetophenone 25 76 
7 4'-Methylacetophenone 42 96 
8 4'-Methoxyacetophenone 47 98 
 
a General conditions: Ketone (0.6 mmol), iPrOH (5 mL), KOH (5 mol%), [1] (5 mol%), anisole (0.3 mmol), 110 °C; b 
determined by GC, based on the average of at least two runs; calibrations indicate that conversions are identical to yields 
under these conditions. 
 
Alcohol oxidation. The series of complexes 1–10 was also tested in the anaerobic oxidation of 
secondary alcohols, where normal NHC analogues of complex 6 featured high activity with TOFmax 
up to 330 h–1.2(c),21 The catalytic reactions were performed using o-dichlorobenzene as solvent, 
hexamethylbenzene (0.1 mmol) as internal standard, at a temperature of 150 °C. In general, all 
complexes catalyze the oxidation at a 5 mol% loading and afforded moderate yields of the 
corresponding ketone (Table 4). Similar to the transfer hydrogenation reaction, the NHC-free 
complexes ([(p-cym)RuCl2]2 or [CpRuCl(PPh3)2] showed very low catalytic activities ( 8% after 18 
hours of reaction time; entries 9,10 in Table 4), indicating a critical role of the tethered aNHC ligand 
for imparting catalytic activity. 
 
In contrast to transfer hydrogenation catalysis, the alcohol dehydrogenation activity of the 
ruthenium(II) center is not dependent on the nature of the ancillary ligand set (p-cym/Cl vs. Cp/PPh3), 
nor on the type of chelating group (N-alkenyl vs. N-picolyl). Conversions after 4 h were generally 
60±5% (72±5% after 24 h) when using the abnormal NHC Ru(II) complexes (Figure S38), reaching 
a modest TOFmax = 9 h–1. Again a notable decrease in catalytic activity is observed with the complexes 
containing substantial amounts of the normal NHC Ru(II) complex (4/5 and 7/8, entries 4, 6). When 
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considering the essentially equal activity of all aNHC Ru complexes, and the 1H NMR 
spectroscopically determined ratios of complexes 4/5 (2:1), the catalytic activities of the normal NHC 
complex in the mixture of 4/5 is estimated to be about half of that of the abnormal NHC complex. 
The same accounts for the 1:1 mixture of 7/8, with the normal NHC imparting only about half the 
catalytic activity from that of the aNHC ligand.  
 
Table 4: Oxidation of ±1-phenylethanol using 1-10 a 
  
Entry Complex 
Conversion c (%) 
4h 24h 
1 1 63 77 
2 2 60 73 
3 3 58 70 
4 4/5 b 50  62  
5 6 62 73 
6 7/8 b 43 56 
7 9 57 74 
8 10 58 68 
9 ([(p-cym)RuCl2]2 n.d. 8 d 
10 [CpRuCl(PPh3)2] n.d. 8 d 
 
a General conditions: ±1-Phenylethanol (1 mmol), o-dichlorobenzene (5 mL), KOtBu (5 mol%), [Ru] (5 mol%), 
hexamethylbenzene (0.1 mmol), 150 °C; b mixture of complexes as isolated after purification; c determined by GC, based 
on the average of at least two runs; d after 18 h. 
 
According to the classical transfer hydrogenation and alcohol oxidation mechanisms for Ru(II) 
catalysts, a mono-hydride intermediate is proposed.26 From the catalysis results of this study it is 
concluded that generation of available coordination sites for catalysis is mediated in different ways 
depending on the complex: (i) For all p-cymene complexes, dehalogenation by either KOH or KOtBu 
generates an available site for substrate coordination – no NMR resonances for free p-cymene could 
be observed for either transfer hydrogenation, or alcohol oxidation reactions; (ii) For all Cp 
complexes, loss of PPh3 as OPPh3 (according to 31P-NMR spectra) generates an available site for 
catalysis; (iii) In both transfer hydrogenation and alcohol oxidation reactions, no hydride signals of 
 
 
18 
 
either p-cymene or Cp catalysts could be observed in their 1H-NMR spectra, and hence it is proposed 
that the mono-hydride intermediate catalytic species are not the resting state intermediate species.  
 
 
Conclusions 
Variation of the arene ligand (p-cymene vs. cyclopentadienyl) and of the chelating tether of aNHC 
ligands (alkenyl vs. picolyl) provided access to six unique half-sandwich aNHC Ru(II) complexes. In 
addition, Ag-mediated C(2)-demethylation resulted in the identification of two normally-bound NHC 
Ru(II) side-products. Symmetrization of the N-alkene substituents of the aNHC ligand, as well as 
employing an iPr-group on the C(2)-position of the imidazolium precursor, prevented C(2)-
dealkylation and allowed for the selective C(4)-ruthenation for both the p-cymene and 
cyclopentadienyl Ru(II) precursors. Preliminary catalytic studies involving transfer hydrogenation 
suggest a greater impact of vacant coordination sites available via halide substitution (p-cymene 
Ru(II) complexes) than via reversible alkene and/or phosphine dissociation (cyclopentadienyl Ru(II) 
complexes). Furthermore, a slight deactivating effect has been observed for both p-cymene and 
cyclopentadienyl aNHC Ru(II) complexes when employing the less labile N-picolyl tether compared 
to alkenyl chelating groups, and when introducing a methyl group on the aNHC ligand C(5) position. 
The transfer hydrogenation results indicate that chelating aNHC ligand systems provide a dynamic 
platform for the development of active, selective, and long-lived catalysts. 
 
 
Experimental Section 
General. All experiments were carried out under an argon atmosphere using standard Schlenk 
techniques. Solvents were dried and distilled from appropriate drying agents prior to use. The new 
imidazolium chloride salts [H(L1-L4)]Cl were synthesized and purified according to standard 
literature procedures (see SI).27 The metal precursor [CpRuCl(PPh3)2] was synthesized according to 
the reported method.22 All other chemicals were purchased from commercial suppliers and used 
without further purification. 1H (300/400 MHz) and 13C{H} (76/100 MHz) NMR spectra were 
recorded on either a Bruker ARX-300 or a Ultrashield Plus 400 AVANCE 3 spectrometer. All 
measurements were performed at ambient temperature (298 K), unless otherwise noted. Chemical 
shifts were referenced to SiMe4 by the internal residual protio solvent resonances. Solid state FT-IR 
experiments were carried out on a Perkin Elmer Spectrum RXI FT-IR spectrometer as pressed KBr 
pellets in air. Microanalytical analyses (%CHNS) were obtained using a Thermo Scientific Flash 
2000 elemental analyzer fitted with a TCD detector. Although some of these results are outside the 
range viewed as establishing analytical purity (values within 0.4%), they are provided to illustrate the 
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best values obtained to date. GC analyses were carried out on a Shimadzu GC-2010 fitted with a 
flame ionization detector (FID) using a TRB-780143 capillary column (30 m, 0.25 mm ID, thickness 
0.25 µm) and an AOC-20i auto injector. Electrospray mass spectra (ESI-MS) were recorded on a 
MicromassQuatro LC instrument.  
 
General synthesis of half-sandwich NHC Ru(II) complexes 1–10.  A suspension of the appropriate 
imidazolium chloride salt [H(L1-L4)]Cl (1 mmol) in CH2Cl2 (20 mL) containing Ag2O (0.23 g, 1 
mmol) was stirred at 30 °C for 12 h in the absence of light. The mixture was filtered to which either 
[(p-cym)RuCl2]2 (0.5 mmol) or [CpRuCl(PPh3)2] (1 mmol) was added and heated under reflux for 
either 5 h ([(p-cym)RuCl2]2) or 36 h ([CpRuCl(PPh3)2]). The crude reaction mixture was filtered and 
the filtrate concentrated in vacuo to 5 mL. Acetone (15 mL) and NH4PF6 (0.16 g, 1 mmol) were added 
and the reaction mixture was stirred for a further hour. The mixture was evaporated in vacuo and 
purified by silica gel column chromatography using gradient elution with CH2Cl2/acetone. Yellow to 
dark-yellow solids were obtained.  
 
Complex 1: Yield: 0.28 g, 49%. 1H NMR ((CD3)2CO): δH = 1.32 (d, 3JHH = 6 Hz, 3H, CH(CH3)2), 
1.34 (d, 3JHH = 6 Hz, 3H, CH(CH3)2), 1.79 (s, 3H, =CCH3), 1.98 (s, 3H, cym–CH3), 2.64 (s, 3H, Cimi–
CH3), 2.78 (septet, 3JHH = 6 Hz, 1H, CHMe2), 3.68 (d, 2JHH = 9 Hz, 1H, NCH2), 3.85 (s, 3H, NCH3), 
4.07 (s, 1H, =CH2), 4.44 (d, 2JHH = 9 Hz, 1H, NCH2), 5.27 (d, 3JHH = 6 Hz, 1H, CcymH), 5.71 (s, 1H, 
=CH2), 5.80 (d, 3JHH = 6 Hz, 1H, CcymH), 6.50 (d, 3JHH = 6 Hz, 1H, CcymH), 6.65 (d, 3JHH = 6 Hz, 1H, 
CcymH), 7.41 (s, 1H, CimiH). 13C{1H} NMR (CDCl3): δC = 14.1 (=CCH3), 19.6 (cym–CH3), 21.0 
(CH(CH3)2), 22.2 (CH(CH3)2), 29.6 Cimi–CH3), 31.8 (cym CMe2), 54.1 (NCH3), 60.3 (NCH2), 80.2 
(=CH2), 81.1 (=CHMe), 96.6 (CcymH), 101.7 (CcymH), 115.2 (CimiH), 121.5 (Ccym–iPr), 122.7 (Ccym–
Me), 137.6 (NCN), 171.1 (C–Ru). 31P{1H} NMR (CDCl3): δP = -144.2 (septet, 1JPF = 713 Hz, PF6). 
CHN found (calcd) for [C19H28ClF6N2PRu]×1.75H2O×0.5CH2Cl2: C, 36.26 (36.60), H, 5.25 (5.12), 
N, 3.98 (4.38)%. HR-MS (ESI): m/z 421.0962 (1+) calcd for C19H28ClN2Ru 421.0985. 
 
Complex 2: Yield: 0.22 g, 38%. 1H NMR ((CD3)2CO): δH = 1.19 (d, 3JHH = 6 Hz, 3H, CH(CH3)2), 
1.24 (d, 3JHH = 6 Hz, 3H, CH(CH3)2), 2.18 (s, 3H, =CCH3), 2.23 (s, 3H, cym–CH3), 2.29 (s, 3H, Cimi–
CH3), 2.35 (s, 3H, Cimi–CH3), 2.79 (septet, 3JHH = 6 Hz, 1H, CHMe2), 3.31 (s, 1H, =CH2), 3.87 (s, 
3H, NCH3), 4.27 (d, 2JHH = 15 Hz, 1H, NCH2), 4.34 (d, 2JHH = 15 Hz, 1H, NCH2), 4.75 (s, 1H, =CH2), 
5.64 (d, 3JHH = 6 Hz, 1H, CcymH), 5.82 (d, 3JHH = 6 Hz, 1H, CcymH), 6.55 (d, 3JHH = 6 Hz, 1H, CcymH), 
6.64 (d, 3JHH = 6 Hz, 1H, CcymH). 13C{1H} NMR (CDCl3): δC = 10.1 (=CCH3), 18.9 (cym–CH3), 22.0 
(CH(CH3)2), 23.9 (CH(CH3)2), 27.8 (Cimi–CH3), 31.4 (cym CMe2), 34.9 (Cimi–CH3), 54.5 (NCH3), 
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70.2 (NCH2), 78.1 (=CH2), 78.9 (=CCH3), 95.0 (CcymH), 97.1 (CcymH), 101.7 (CcymH), 108.9 
(CimiMe), 117.2 (Ccym–iPr), 133.4 (NCN), 168.8 (C–Ru). 31P{1H} NMR (CDCl3): δP = -144.3 (septet, 
1JPF = 713 Hz, PF6). CHN found (calcd) for [C20H30ClF6N2PRu]×0.63CHCl3: C, 38.24 (37.84), H, 
4.30 (4.71), N, 4.31 (4.28)%. HR-MS (ESI): m/z 435.1152 (2+) calcd for C20H30ClN2Ru 435.1141. 
 
Complex 3: Yield: 0.17 g, 23%. 1H NMR ((CD3)2CO): δH = 1.70 (d, 2JHH = 12 Hz, 1H, NCH2), 1.80 
(s, 3H, =CCH3), 2.31 (d, 3JHP = 12 Hz, 1H, =CH2), 2.34 (s, 3H, Cimi–CH3), 3.71 (s, 3H, NCH3), 3.80 
(s, 1H, =CH2), 3.88 (d, 2JHH = 12 Hz, 1H, NCH2), 4.97 (s, 5H, C5H5), 7.02 (s, 1H, CimiH), 7.38-7.49 
(m, 15H, HPh). 13C{1H} NMR (CDCl3): δC = 10.2 (=CCH3), 31.2 (Cimi–CH3), 45.7 (NCH3), 56.8 
(NCH2), 76.3 (=CH2), 76.6 (=CCH3), 87.8 (C5H5), 128.0 (CimiH), 128.7 (CPh), 130.3 (CPh), 133.5 
(CPh), 135.2 (ipso-CPh), 139.2 (NCN), 147.0 (C–Ru). 31P{1H} NMR (CDCl3): δP = -144.2 (septet, 1JPF 
= 708 Hz, PF6), 56.8 (s, PPh3). CHN (%) found (calcd) for [C32H34F6N2P2Ru]×2.22(CH3)2CO: C, 
54.06 (54.46), H, 5.98 (5.59), N, 3.23 (3.29)%.  HR-MS (ESI): m/z 579.1514 (3+)  calcd for 
C32H34N2PRu 579.1503. 
 
Complexes 4 and 5: Complexes 4 and 5 eluted together in a 2:1 ratio. Combined yield: 0.28 g (39%); 
By NMR 24% (4), 15% (5). Spectroscopic data of 4: 1H NMR (CDCl3): δH = 1.45 (d, 2JHH = 12 Hz, 
1H, NCH2), 1.85 (s, 3H, =CCH3), 2.03 (d, 3JHP = 12 Hz, 1H, =CH2), 2.25 (s, 3H, Cimi–CH3), 2.47 (s, 
3H, NCH3), 2.92 (s, 3H, Cimi–CH3), 3.53 (d, 2JHH = 12 Hz, 1H, NCH2), 3.78 (s, 1H, =CH2), 5.02 (s, 
5H, C5H5), 7.31-7.49 (m, 15H, HPh). 13C{1H} NMR ((CD3)2CO): δC = 9.3 (=CCH3), 31.8 (Cimi–CH3), 
33.9 (Cimi–CH3), 47.6 (NCH3), 56.6 (NCH2), 78.4 (=CH2), 79.8 (=CCH3), 88.2 (C5H5), 117.8 
(CimiMe), 128.7 (CPh), 130.5 (CPh), 131.7 (CPh), 133.5 (ipso-CPh), 134.3 (NCN), 149.7 (C–Ru). 
31P{1H} NMR (CDCl3): δP = -144.2 (septet, 1JPF = 708 Hz, PF6), 56.7 (s, PPh3). Spectroscopic data 
of 5: 1H NMR (CDCl3): δH =  1.70 (s, 3H, =CCH3), 2.19 (s, 3H, Cimi–CH3), 2.51 (s, 3H, NCH3), 4.36 
(s, 1H, =CH2), 4.49 (s, 1H, NCH2), 4.64 (s, 1H, =CH2), 5.02 (s, 5H, C5H5), 5.03 (d, 2JHH = 12 Hz, 1H, 
NCH2), 6.74 (s, 1H, CimiH), 7.52-7.66 (m, 15H, HPh). 13C{1H} NMR ((CD3)2CO): δC = 9.5 (=CCH3), 
31.4 (Cimi–CH3), 47.6 (NCH3), 54.4 (NCH2), 75.8 (=CH2), 81.4 (=CCH3), 87.8 (C5H5), 114.6 
(CimiMe), 121.0 (CimiH), 128.6 (CPh), 130.3 (CPh), 131.9 (CPh), 132.7 (ipso-CPh), 174.0 (C–Ru). 
31P{1H} NMR (CDCl3): δP = -144.2 (septet, 1JPF = 708 Hz, PF6), 57.7 (s, PPh3). CHN (%) found 
(calcd) for [C33H36F6N2P2Ru]×0.5[C32H34F6N2P2Ru]×0.31CHCl3: C, 53.22 (52.82), H, 4.26 (4.79), 
N, 4.01 (3.76)%.  HR-MS (ESI): m/z 593.1619 (4+), 579.1501 (5+)  calcd for C33H36N2PRu (4) 
593.1661, C32H34N2PRu (5) 579.1503. 
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Complex 6: Yield: 0.22 g, 38%. 1H NMR (CDCl3): δH = 1.20 (d, 3JHH = 9 Hz, 3H, CH(CH3)2), 1.22 
(d, 3JHH = 9 Hz, 3H, CH(CH3)2), 1.85 (s, 3H, Cimi–CH3), 2.62 (s, 3H, cym–CH3), 2.75 (septet, 3JHH = 
9 Hz, 1H, CHMe2), 3.62 (s, 3H, NCH3), 4.88 (d, 2JHH = 15 Hz, 1H, NCH2), 5.17 (d, 3JHH = 6 Hz, 1H, 
CcymH), 5.35 (d, 2JHH = 15 Hz, 1H, NCH2), 5.52 (s, 2H, CcymH), 5.57 (d, 3JHH = 6 Hz, 1H, CcymH), 
6.58 (s, 1H, CimiH), 7.32 (t, 3JHH = 6 Hz, 1H, C5H4N), 7.61 (d, 3JHH = 6 Hz, 1H, C5H4N), 7.77 (t, 3JHH 
= 6 Hz, 1H, C5H4N), 9.36 (d, 3JHH = 6 Hz, 1H, C5H4N). 13C{1H} NMR (CDCl3): δC = 9.52 (Cimi–
CH3), 18.1 (cym–CH3), 22.3 (CH(CH3)2), 22.5 (CH(CH3)2), 30.6 (cym CMe2), 34.4 (NCH3), 53.0 
(NCH2), 82.0 (CcymH), 86.1 (CcymH), 88.6 (CcymH), 99.5 (CcymH), 107.1 (Cpy), 124.6 (CimiH), 125.1 
(Ccym–iPr), 125.2 (Cpy), 125.5 (Ccym–Me), 139.1 (NCN), 141.9 (Cpy), 150.0 (Cpy), 156.0 (Cpy), 157.8 
(C–Ru). 31P{1H} NMR (CDCl3): δP = -144.3 (septet, 1JPF = 709 Hz, PF6). CHN (%) found (calcd) for 
[C21H27ClF6N3PRu]×0.47CH2Cl2: C, 40.52 (40.12), H, 4.52 (4.38), N, 6.17 (6.54)%. HR-MS (ESI): 
m/z 458.0948 (6+) calcd for C21H27ClN3Ru 458.0941. 
 
Complexes 7 and 8: Complexes 7 and 8 were obtained as a 1:1 mixture that co-elutes by column 
chromatography and co-crystallizes upon recrystallization. Combined yield: 0.28 g, 37%; By NMR: 
19% (7); 18% (8). Spectroscopic data of 7: 1H NMR (CDCl3): δH = 2.17 (s, 3H, Cimi–CH3), 3.35 (s, 
3H, NCH3), 4.75 (s, 5H, C5H5), 4.80 (d, 2JHH = 18 Hz, 1H, NCH2), 5.38 (d, 2JHH = 18 Hz, 1H, NCH2), 
6.64 (s, 1H, CimiH), 6.87-6.92 (m, 5H, HPh), 7.21-7.36 (m, 10H, HPh), 7.41-7.54 (m, 3H, Hpy), 8.25 
(d, 3JHH = 6 Hz, 1H, Hpy). 13C{1H} NMR (CDCl3): δC = 9.6 (Cimi–CH3), 37.3 (NCH3), 55.1 (NCH2), 
77.6 (C5H5), 122.5 (CimiH), 125.4 (C5H4N), 128.1 (CPh), 129.4 (CPh), 129.8 (CPh), 133.1 (Cpy), 133.5 
(ipso-CPh), 135.3 (Cpy), 135.9 (NCN), 137.6 (Cpy), 157.3 (Cpy), 159.9 (C–Ru). 31P{1H} NMR (CDCl3): 
δP = -144.2 (septet, 1JPF = 708 Hz, PF6), 56.8 (s, PPh3). Spectroscopic data of 8: 1H NMR (CDCl3): 
δH = 2.99 (s, 1H, NCH3), 4.40 (s, 5H, C5H5), 4.85 (d, 2JHH = 18 Hz, 1H, NCH2), 5.34 (d, 2JHH = 18 
Hz, 1H, NCH2), 6.34 (s, 1H, CimiH), 6.44 (s, 1H, CimiH), 6.87-6.92 (m, 5H, HPh), 7.21-7.36 (m, 10H, 
HPh), 7.41-7.54 (m, 3H, Hpy), 7.69 (d, 3JHH = 6 Hz, 1H, Hpy). 13C{1H} NMR (CDCl3): δC = 33.9 
(NCH3), 53.9 (NCH2), 77.2 (C5H5), 123.3 (CimiH), 125.3 (CimiH), 128.0 (Cpy), 128.5 (CPh), 128.7 
(CPh), 130.0 (CPh), 133.0 (Cpy), 133.6 (ipso-CPh), 135.3 (Cpy), 137.0 (Cpy), 156.7 (Cpy), 184.4 (C–Ru). 
31P{1H} NMR (CDCl3): δP = -144.2 (septet, 1JPF = 708 Hz, PF6), 56.0 (s, PPh3). CHN (%) found 
(calcd) for [C34H33F6N3P2Ru]×[C33H31F6N3P2Ru]×2CH2Cl2: C, 49.03 (49.41), H, 4.47 (4.09), N, 5.23 
(5.01)%. HR-MS (ESI): m/z 616.1520 (7+), 602.1279 (8+) calcd for C34H33N3PRu (7) 616.1460, 
C33H31N3PRu (8) 602.1304. 
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Complex 9: Yield: 0.39 g, 62%. 1H NMR (CDCl3): δH = 1.23 (d, 3JHH = 6 Hz, 3H, CH(CH3)2), 1.25 
(d, 3JHH = 6 Hz, 3H, CH(CH3)2), 1.29 (d, 3JHH = 6 Hz, 3H, CH(CH3)2), 1.34 (d, 3JHH = 6 Hz, 3H, 
CH(CH3)2), 1.66 (s, 3H, =CCH3), 1.74 (s, 3H,  =CCH3), 1.88 (s, 3H, cym–CH3), 2.69 (septet, 3JHH = 
6 Hz, 1H, cym-CHMe2), 3.23 (septet, 3JHH = 6 Hz, 1H, imi–CHMe2), 3.73 (d, 2JHH = 12 Hz, 1H, 
NCH2), 4.03 (s, 1H, =CH2), 4.25 (d, 2JHH = 12 Hz, 1H, NCH2), 4.57 (s, 2H, =CH2), 4.61 (d, 2JHH = 
12 Hz, 1H, NCH2), 4.99 (d, 2JHH = 12 Hz, 1H, NCH2), 5.02 (d, 3JHH = 6 Hz, 1H, CcymH), 5.51 (s, 1H, 
=CH2), 5.63 (d, 3JHH = 6 Hz, 1H, CcymH), 6.28 (d, 3JHH = 6 Hz, 1H, CcymH), 6.42 (d, 3JHH = 6 Hz, 1H, 
CcymH), 7.17 (s, 1H, CimiH). 13C{1H} NMR (CDCl3): δC = 15.2 (=CCH3), 17.3 (=CCH3), 18.8 (cym–
CH3), 19.4 (CH(CH3)2), 19.6 (CH(CH3)2), 24.2 (CH(CH3)2), 24.9 (CH(CH3)2), 26.6 (CMe2), 30.7 
(CMe2), 53.2 (NCH2), 56.1 (NCH2), 90.5 (=CH2), 93.4 (=CH2), 95.6 (=CCH3), 98.2 (=CCH3), 99.4 
(CcymH), 103.5 (CcymH), 113.4 (CcymH), 118.7 (CcymH), 125.7 (CimiH), 139.5 (NCN), 146.8 (Ccym–
iPr), 148.0 (Ccym–Me), 152.3 (C–Ru). 31P{1H} NMR (CDCl3): δP = -144.2 (septet, 1JPF = 710 Hz, 
PF6). CHN (%) found (calcd) for [C24H36ClF6N2PRu]×0.4CHCl3: C, 42.73 (42.98), H, 5.29 (5.38), 
N, 3.89 (4.11)%. HR-MS (ESI): m/z 489.1612 (9+) calcd for C24H36ClN2Ru 489.1614. 
 
Complex 10: Yield: 0.43 g, 54%. 1H NMR (CDCl3): δH = 1.01 (d, 3JHH = 9 Hz, 3H, CH(CH3)2), 1.24 
(d, 3JHH = 9 Hz, 3H, CH(CH3)2), 1.55 (s, 3H, =CCH3), 1.74 (s, 3H, =CCH3), 1.88 (d, 2JHH = 15 Hz, 
1H, NCH2), 2.27 (d, 3JHP = 12 Hz, 1H, =CH2), 3.11 (septet, 3JHH = 9 Hz, 1H, CHMe2), 3.65 (s, 1H, 
=CH2), 3.84 (d, 2JHH = 15 Hz, 1H, NCH2), 4.47 (d, 2JHH = 15 Hz, 1H, NCH2), 4.48 (s, 1H, =CH2), 
4.58 (d, 2JHH = 15 Hz, 1H, NCH2), 4.79 (s, 5H, C5H5), 5.28 (s, 1H, =CH2), 6.75 (s, 1H, CimiH), 7.19-
7.36 (m, 15H, HPh). 13C{1H} NMR (CDCl3): δC = 19.4 (=CCH3), 24.6 (=CCH3), 25.6 (CH(CH3)2), 
30.7 (CMe2), 45.1 (NCH2), 53.0 (NCH2), 53.4 (=CH2), 58.2 (=CCH3), 68.0 (=CH2), 77.2 (=CCH3), 
88.3 (C5H5), 113.0 (CimiH), 128.2 (CPh), 133.3 (CPh), 135.5 (CPh), 140.1 (ipso-CPh), 146.3 (NCN), 
148.6 (C–Ru). 31P{1H} NMR (CDCl3): δP = -144.2 (septet, 1JPF = 710 Hz, PF6), 57.9 (s, PPh3). CHN 
(%) found (calcd) for [C37H42F6N2P2Ru]×0.5H2O: C, 55.35 (55.50), H, 5.62 (5.41), N, 3.13 (3.50)%. 
HR-MS (ESI): m/z 647.2150 (10+) calcd for C37H42N2PRu 647.2130. 
 
Typical procedure for transfer hydrogenation catalysis. To a round-bottom flask containing 
benzophenone (109 mg, 0.6 mmol), base (4 mg, 0.03 mmol, 5 mol%), anisole as internal standard (22 
μL, 0.2 mmol), and ruthenium complex (6 μmol, 1 mol%) was added 2-propanol (4 mL) and the 
reaction mixture was heated to reflux for the time indicated. Aliquots (0.05 mL) of the reaction 
mixture taken at specified times were diluted with 2-propanol, and analyzed by GC. Conversions 
were determined relative to anisole as the internal standard. Aliquots (0.05 mL) diluted with CDCl3 
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were analyzed by 1H NMR spectroscopy for selected catalytic experiments. More consistent values 
were determined using GC analysis and conversions were determined relative to anisole as the 
internal standard. All yields are based on the average of at least two runs. 
 
Typical procedure for alcohol oxidation catalysis. To a round-bottom flask containing ±1-
phenylethanol (0.121 mg, 1 mmol), KOtBu (6 mg, 0.05 mmol, 5 mol%), hexamethylbenzene as 
internal standard (18 mg, 0.1 mmol), and the ruthenium complex (0.05 mmol, 5 mol%) was added o-
dichlorobenzene (4 mL) and the reaction mixture was stirred at 150 °C for the time indicated. Aliquots 
(0.05 mL) of the reaction mixture were diluted with 2-propanol, and conversions were determined by 
GC analysis relative to hexamethylbenzene as the internal standard. All yields are based on the 
average of at least two runs. 
 
X-ray crystallography of [HL1]Cl, [HL4]Cl, 1, 3, 4, 5, 6, 7/8.CH2Cl2, 7/8.CHCl3 and 10. Single 
crystal diffraction studies of the compounds were done using either Quazar multi-layer optics 
monochromated Mo Kα radiation (k = 0.71073 Å) on a Bruker D8 Venture kappa geometry 
diffractometer with duo Is sources, a Photon 100 CMOS detector and APEX II control software28 
([HL1]Cl, [HL4]Cl, 3, 6, 7/8.CH2Cl2, 7/8.CHCl3, and 10), or an Oxford Diffraction SuperNova area-
detector diffractometer29 using mirror optics monochromated Mo Kα radiation (λ = 0.71073 Å) and 
Al filtered30 (1, 5). X-ray diffraction measurements were performed at either 123(2) K (1, 5), 150(2) 
K ([HL1]Cl, 3, 6, 7/8.CH2Cl2, 7/8.CHCl3), or 298(2) K ([HL4]Cl, 10).  Data reduction was performed 
using the CrysAlisPro29 program. The intensities were corrected for Lorentz and polarization effects, 
and an absorption correction based on the multi-scan method using SCALE3 ABSPACK in 
CrysAlisPro29 was applied (1, 5). For the remaining compounds: Data reduction was performed using 
SAINT+28 and the intensities were corrected for absorption using SADABS.28 The structures were 
solved by direct methods using SHELXT31 using the SHELXL-2014/732 program. The non-hydrogen 
atoms were refined anisotropically. All H atoms were placed in geometrically idealized positions and 
constrained to ride on their parent atoms. For a table containing the data collection and refinement 
parameters, see Tables S1-S3 in SI. Crystallographic data for all structures have been deposited with 
the Cambridge Crystallographic Data Centre (CCDC) as supplementary publication numbers) 
1843098 ([HL1]Cl), 1843100 ([HL4]Cl), 1843096 (1), 1843103 (3), 1843097 (5), 1843099 (6), 
1843101 (7/8.CH2Cl2), 1843102 (7/8.CHCl3), and 1843104 (10). 
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